Negative regulation of inflammation during Klebsiella pneumoniae infection

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 5R21AI153549-02

Grant search

Key facts

  • Disease

    Bacterial infection caused by Klebsiella pneumonia
  • Start & end year

    2021
    2024
  • Known Financial Commitments (USD)

    $198,230
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Giraldina Trevejo-Nunez
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF PITTSBURGH AT PITTSBURGH
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project Summary Infections with Klebsiella pneumoniae (KP) activate the IL-17 signaling pathway, which is crucial to constrain KP dissemination and facilitate pathogen eradication. During this process, IL-17 is negatively regulated by RNA binding proteins (RBP) in an effort to decrease collateral tissue damage in the host. One of these RBPs is Regnase-1 (Reg1) which degrades IL-17- induced transcripts either through the coding region or 3'UTR. In this proposal, we will investigate the role of Reg1 in the airway epithelium during KP pneumonia. We hypothesize that Reg1 deficiency enhances the effect of pro-inflammatory transcripts in the airway epithelium which favors immunity against KP. For that purpose, we will characterize a Reg1 conditional knockout in the airway epithelium upon KP pneumonia as well as investigate Reg1 regulation at the epigenetic and post-transcriptional level.